SRM Medical College Hospital and Research Centre has a state of the art Biosafety Level 3, NABL accredited Molecular diagnostic center which was inaugurated on September 2020. COVID (SARS CoV2) Real time PCR- qualitative assay and Hepatitis C RT PCR is performed at the laboratory. A total of 11,358 samples were processed from January 2021 to June 30th 2021 for effective management of COVID 19 second wave. 46 samples for HCV RNA RT PCR were processed in the first six months of the calendar year 2021.
We have been selected as one of the sites for COVAXIN clinical trial which is currently in Phase 3. We have processed 2100 samples as of June 30th 2021 as part of this trial.
The laboratory is currently in collaboration with WHO on two study projects. Study 1 is aimed at evaluating the seroprevalence of COVID Total Ig antibodies among healthcare workers in India.
Study 2 is aimed at analyzing the effectiveness of COVAXIN and COVISHIELD vaccines against severe COVID 19. It is a multicentric hospital based – case control study. We have recruited 87 cases and 243 control subjects as of June 30th 2021 in the study.